| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/03/2004 | US6686467 Inhibitors of the production of cytokines such as tumour necrosis factor (hereinafter tnf), for example tnf alpha , and various members of the interleukin (hereinafter il) family, for example il-1, il-6 and il-8 |
| 02/03/2004 | US6686388 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 02/03/2004 | US6686384 2-anilinophenyl-substituted; inhibition of the na+/h+ exchanger |
| 02/03/2004 | US6686382 N-(isoxazolyl)thienylsulfonamides, n-(isoxazolyl)furylsulfonamides, n-(isoxazolyl)pyrrolylsulfonamides and n-(isoxazolyl)phenylsulfonamides; inhibit endothelin |
| 02/03/2004 | US6686367 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 02/03/2004 | US6686358 Anticoagulants; cardoviscular disorders |
| 02/03/2004 | US6686335 Hydroxamate-containing cysteine and serine protease inhibitors |
| 02/03/2004 | US6686153 PRV-1 gene and the use thereof |
| 02/03/2004 | US6685950 Methods of treating viral infections |
| 02/03/2004 | CA2100655C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 02/03/2004 | CA2091636C Method for suppressing coloring of human serum albumin |
| 01/31/2004 | CA2436469A1 Composition for heart disease, method to prepare same and uses thereof |
| 01/29/2004 | WO2004009816A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/29/2004 | WO2004009784A2 Novel inhibitors of kinases |
| 01/29/2004 | WO2004009641A1 aPC NON-NEUTRALIZING ANTIBODY |
| 01/29/2004 | WO2004009601A1 Azaindole kinase inhibitors |
| 01/29/2004 | WO2004009588A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/29/2004 | WO2004009586A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 01/29/2004 | WO2004009582A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | WO2004009579A1 Novel compounds |
| 01/29/2004 | WO2004009575A1 An extract of a typhae pollen and its manufacture and use |
| 01/29/2004 | WO2004009565A2 Acylaminothiazole derivatives, preparation and therapeutic use thereof |
| 01/29/2004 | WO2004009560A1 Novel bio-active molecules |
| 01/29/2004 | WO2004009547A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | WO2004009537A1 NOVEL α-KETOAMIDE DERIVATIVE AND USE THEREOF |
| 01/29/2004 | WO2004009536A1 Novel compounds as histone deacetylase inhibitors |
| 01/29/2004 | WO2004009533A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/29/2004 | WO2004009123A2 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 01/29/2004 | WO2004009058A1 Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate |
| 01/29/2004 | WO2003088748A8 Use of heme oxygenase-1 and products of heme degradation |
| 01/29/2004 | WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/29/2004 | WO2003053923A3 Pyrrolidine derivatives as prostaglandin modulators |
| 01/29/2004 | WO2003040080A3 Lipoxin a4 analogs |
| 01/29/2004 | WO2003028654A3 Storage-stable human fibrinogen solutions |
| 01/29/2004 | WO2003020324A3 Methods for sterilizing preparations of digestive enzymes |
| 01/29/2004 | WO2002072794A3 Immunoglobulin superfamily proteins |
| 01/29/2004 | US20040019190 Thrombopoietin mimetics |
| 01/29/2004 | US20040019186 Complex of lecithin and sugar; immobilization; washing; liquid removal; recovering |
| 01/29/2004 | US20040019114 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical |
| 01/29/2004 | US20040019094 N-imine guanidine compounds; treatment of obesity, anorexia, inflammation and mental disorders |
| 01/29/2004 | US20040019077 Heterocyclic imines such as N1-(8-sulfonamide-5-isoquinoline)-N2-(3,3-diphenyl-2-propenyl) -ethylenediamine, used for prophylaxis and diagnosis of cancers, diabetes, cardiovascular and nervous system disorders, autoimmune diseases or obesity |
| 01/29/2004 | US20040019052 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 01/29/2004 | US20040019045 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/29/2004 | US20040019038 Compounds useful as anti-inflammatory agents |
| 01/29/2004 | US20040019037 E.g.,((5-(2,4-Diaminopyrimidin-6-yl)pentanoyl)-(N-methyl)amino )-3-(6-meth-oxypyridin-3-yl)-propanoic acid, inhibition of bone resorption, restenosis, angiogenesis inhibitors, antiarthritic, -tumor, -carcinogenic agents; antidiabetic |
| 01/29/2004 | US20040019020 Phosphinyl phosphonate compounds treat hyperphosphatemia, chronic renal failure, disorders of phosphate metabolism, hyperparathyroidism, uremic bone disease, soft tissue calcification or osteoporosis |
| 01/29/2004 | US20040018972 Autoimmune diseases; antiallergens; rheumatic diseases; antiinflammatory agents |
| 01/29/2004 | US20040018966 Methods and compositions for use in perfusion applications |
| 01/29/2004 | US20040018618 Genetic engineering; hybrid proteins; gene expression; human gene therapy |
| 01/29/2004 | US20040018533 Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions |
| 01/29/2004 | US20040018516 Ixodes scapularis tissue factor pathway inhibitor |
| 01/29/2004 | US20040018261 Extract of Typhae Pollen traditional Chinese medicine consisting of flavonoids as active components includes kaempferol, quercetin and isorhamnetin; for lowering blood lipid level, preventing arteriosclerosis, coagulation |
| 01/29/2004 | US20040018192 Integrin expression inhibitors |
| 01/29/2004 | DE10229379A1 EG-VEGF Rezeptor Antagonisten EG-VEGF receptor antagonists |
| 01/29/2004 | CA2493457A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/29/2004 | CA2492922A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | CA2492862A1 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 01/29/2004 | CA2492665A1 Azaindole kinase inhibitors |
| 01/29/2004 | CA2492110A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/29/2004 | CA2491131A1 Novel compounds as histone deacetylase inhibitors |
| 01/29/2004 | CA2466288A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/28/2004 | EP1384725A2 Factor Xa inhibitors |
| 01/28/2004 | EP1384485A1 Bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections |
| 01/28/2004 | EP1383927A2 New polynucleotides and polypeptides of the erythropoietin gene |
| 01/28/2004 | EP1383895A2 Polynucleotides and polypeptides of the ifnalpha-5 gene |
| 01/28/2004 | EP1383892A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/28/2004 | EP1383798A2 Transporters and ion channels |
| 01/28/2004 | EP1383789A2 Proteins associated with cell growth, differentiation, and death |
| 01/28/2004 | EP1383768A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 01/28/2004 | EP1383762A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 01/28/2004 | EP1383756A1 Coumarin derivatives to be used as anticoagulants |
| 01/28/2004 | EP1383750A2 Urea derivatives as integrin alpha 4 antagonists |
| 01/28/2004 | EP1383747A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
| 01/28/2004 | EP1383544A1 Anti-cd19 immunotoxins |
| 01/28/2004 | EP1383531A2 Use of lp82 to treat hematopoietic disorders |
| 01/28/2004 | EP1383524A2 Method for purifying a biological composition |
| 01/28/2004 | EP1383518A1 Oral delivery of macromolecules |
| 01/28/2004 | EP1383515A1 Activation of natural killer cells by adenosine a3 receptor agonists |
| 01/28/2004 | EP1383385A1 Use of ppar-alpha-gamma ligands or agonists to prevent the rupture of atherosclerotic plaques |
| 01/28/2004 | EP1299378A4 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/28/2004 | CN1471536A Chemokine receptor antagonsis and method of use thereof |
| 01/28/2004 | CN1471519A Amino alkyenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1471517A OXAZOLYL-arylpropionic acid derivatives and their sue as PPAR agonists |
| 01/28/2004 | CN1471508A Selective androgen receptor modulators and methods of use thereof |
| 01/28/2004 | CN1471407A Multifunctional nano device platform |
| 01/28/2004 | CN1471390A Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction |
| 01/28/2004 | CN1136213C New benzothiophene, benzofuran and indole compounds, preparation method there for and medicine composition containing them |
| 01/28/2004 | CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them |
| 01/28/2004 | CN1135995C Composite thrombolytic medicine |
| 01/28/2004 | CN1135987C Use of 1-acyl-3,6-hexahydroxy dephenyl-diformacyl glucose compound in preparing medicine for anti-thrombus |
| 01/28/2004 | CN1135976C Application of cotucine in pharmacy |
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6683192 Substituted benzo(b)thien compounds useful for modulating proliferation or differentiation of a cell, agonizes hedgehog mediated signal trasnduction with an ed50 of 1mm or less |
| 01/27/2004 | US6683104 Cholesterol and triglyceride-modulating drugs and methods |
| 01/27/2004 | US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 01/27/2004 | US6683088 Sulfonamido ether substituted imidazoquinolines |
| 01/27/2004 | US6683081 Triazolotriazinones and the use thereof |
| 01/27/2004 | US6683078 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/27/2004 | US6683056 Synergistic mixture with antilipemic agent |